These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 19505397)
1. Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption. Laganà B; Picchianti Diamanti A; Ferlito C; Germano V; Migliore A; Cremona A; Argento G; David V; Salemi S; D'Amelio R Int J Immunopathol Pharmacol; 2009; 22(2):447-54. PubMed ID: 19505397 [TBL] [Abstract][Full Text] [Related]
2. Can the association of Ciclosporine A and Methotrexate maintain remission/low disease activity induced by etanercept in early Rheumatoid Arthritis patients? Evaluation by Magnetic Resonance Imaging. Picchianti Diamanti A; Argento G; Podestà E; Germano V; Fazi S; Migliore A; David V; D'Amelio R; Laganà B Int J Immunopathol Pharmacol; 2012; 25(1):301-5. PubMed ID: 22507346 [TBL] [Abstract][Full Text] [Related]
3. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related]
4. Effect of very early treatment in rheumatoid arthritis on bone oedema and synovitis, using magnetic resonance imaging. Kosta PE; Voulgari PV; Zikou AK; Tsampoulas K; Drosos AA; Argyropoulou MI Scand J Rheumatol; 2012 Oct; 41(5):339-44. PubMed ID: 22646866 [TBL] [Abstract][Full Text] [Related]
5. Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2). Gibofsky A; Cannon GW; Harrison DJ; Joseph GJ; Bitman B; Chaudhari S; Collier DH Clin Exp Rheumatol; 2015; 33(3):297-301. PubMed ID: 25738333 [TBL] [Abstract][Full Text] [Related]
6. MRI evidence of persistent joint inflammation and progressive joint damage despite clinical remission during treatment of early rheumatoid arthritis. Forslind K; Svensson B Scand J Rheumatol; 2016; 45(2):99-102. PubMed ID: 26313244 [TBL] [Abstract][Full Text] [Related]
7. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. van der Heijde D; Klareskog L; Rodriguez-Valverde V; Codreanu C; Bolosiu H; Melo-Gomes J; Tornero-Molina J; Wajdula J; Pedersen R; Fatenejad S; Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441 [TBL] [Abstract][Full Text] [Related]
8. Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging. Hirose W; Nishikawa K; Hirose M; Nanki T; Sugimoto H Mod Rheumatol; 2009; 19(1):20-6. PubMed ID: 18762862 [TBL] [Abstract][Full Text] [Related]
9. May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot study. Migliore A; Massafra U; Bizzi E; Argento G; Diamanti AP; Germano V; Tormenta S; Arduini F; Iannessi F; Granatas M; Laganà B Eur Rev Med Pharmacol Sci; 2012 Mar; 16(3):363-9. PubMed ID: 22530354 [TBL] [Abstract][Full Text] [Related]
10. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689 [TBL] [Abstract][Full Text] [Related]
11. Association of bone edema with the progression of bone erosions quantified by hand magnetic resonance imaging in patients with rheumatoid arthritis in remission. Lisbona MP; Pàmies A; Ares J; Almirall M; Navallas M; Solano A; Maymó J J Rheumatol; 2014 Aug; 41(8):1623-9. PubMed ID: 24986851 [TBL] [Abstract][Full Text] [Related]
12. Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study. Emery P; Kvien TK; Combe B; Freundlich B; Robertson D; Ferdousi T; Bananis E; Pedersen R; Koenig AS Ann Rheum Dis; 2012 Jun; 71(6):989-92. PubMed ID: 22402142 [TBL] [Abstract][Full Text] [Related]
13. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189 [TBL] [Abstract][Full Text] [Related]
14. Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose. Raffeiner B; Botsios C; Ometto F; Bernardi L; Stramare R; Todesco S; Sfriso P; Punzi L Clin Exp Rheumatol; 2015; 33(1):63-8. PubMed ID: 25535985 [TBL] [Abstract][Full Text] [Related]
15. Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study. Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T J Rheumatol; 2011 Aug; 38(8):1585-92. PubMed ID: 21572151 [TBL] [Abstract][Full Text] [Related]
16. Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity-results from the ENCOURAGE study, a prospective, international, multicenter randomized study. Yamanaka H; Nagaoka S; Lee SK; Bae SC; Kasama T; Kobayashi H; Nishioka Y; Ueki Y; Seto Y; Nishinarita M; Tamura N; Kimura N; Saito K; Tomita T; Nawata Y; Suzuki S; Ishigatsubo Y; Munakata Y; Makino Y; Inoue E; Tanaka Y; Takeuchi T; Mod Rheumatol; 2016 Sep; 26(5):651-61. PubMed ID: 26698929 [TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial. Nam JL; Villeneuve E; Hensor EM; Wakefield RJ; Conaghan PG; Green MJ; Gough A; Quinn M; Reece R; Cox SR; Buch MH; van der Heijde DM; Emery P Ann Rheum Dis; 2014 Jun; 73(6):1027-36. PubMed ID: 24618266 [TBL] [Abstract][Full Text] [Related]
18. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Conaghan PG; O'Connor P; McGonagle D; Astin P; Wakefield RJ; Gibbon WW; Quinn M; Karim Z; Green MJ; Proudman S; Isaacs J; Emery P Arthritis Rheum; 2003 Jan; 48(1):64-71. PubMed ID: 12528105 [TBL] [Abstract][Full Text] [Related]
19. Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial. Kameda H; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Takeuchi T; Mod Rheumatol; 2010 Dec; 20(6):531-8. PubMed ID: 20574649 [TBL] [Abstract][Full Text] [Related]
20. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis. Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]